Home > Boards > US Listed > Medical - Healthcare > Biocept, Inc. (BIOC)

BIOC United States Patent January 7, 2020

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
CrazyMoney101 Member Profile
 
Followed By 2,033
Posts 135,441
Boards Moderated 0
Alias Born 04/13/06
160x600 placeholder
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/21/2020 4:57:44 PM
Biocept to Participate in Maxim Group's COVID-19 Virtual Conference Series on May 27, 2020 PR Newswire (US) - 5/20/2020 8:05:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/14/2020 5:28:57 PM
Biocept Expands its Menu of Molecular Assay Kit Offering with Release of its Target Selector™ BRAF Kit for Clients' Use in ... PR Newswire (US) - 5/14/2020 8:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/13/2020 4:18:53 PM
Biocept Reports First Quarter 2020 Financial Results PR Newswire (US) - 5/13/2020 4:05:00 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/11/2020 6:01:00 AM
Biocept to Release First Quarter 2020 Financial Results and Host Investor Conference Call on May 13, 2020 PR Newswire (US) - 4/29/2020 8:05:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/29/2020 7:56:14 AM
Biocept Announces CE-IVD Mark and Availability of its Target Selector™ EGFR Molecular Assay Kit in Europe PR Newswire (US) - 4/28/2020 8:05:00 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 4/24/2020 4:51:59 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/22/2020 12:28:56 PM
Biocept Launches Unique Line of Molecular Assay Kits for Detection of Key Oncogene Mutations Based on its Proprietary Target ... PR Newswire (US) - 4/20/2020 8:05:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 4/20/2020 6:01:08 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/15/2020 6:23:17 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 4/15/2020 6:08:15 AM
Biocept Announces Pricing of $10.3 Million Registered Direct Offering Priced At-The-Market PR Newswire (US) - 4/14/2020 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/13/2020 6:48:05 AM
Biocept to Begin COVID-19 Testing PR Newswire (US) - 4/9/2020 7:17:00 PM
Brazil Patent Granted for Biocept's Target Selector™ Oncogene Mutation Enrichment and Detection Platform PR Newswire (US) - 4/9/2020 8:05:00 AM
Australia Patent Issued for Primer-Switch Mutation Detection and Amplification Platform PR Newswire (US) - 4/2/2020 8:05:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/27/2020 5:23:33 PM
Biocept Enters into Laboratory Services Agreement with Second California-Based Independent Physician Association PR Newswire (US) - 3/26/2020 8:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/25/2020 4:13:08 PM
Biocept Reports 2019 Fourth Quarter and Full Year Financial Results PR Newswire (US) - 3/25/2020 4:05:00 PM
CrazyMoney101   Wednesday, 01/08/20 07:13:08 AM
Re: INTL post# 2173
Post # of 4423 
BIOC United States Patent January 7, 2020

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist